Maintenance Therapy with Gemcitabine Extends Mesothelioma Survival in Dutch Study
Dutch researchers say administering maintenance therapy with gemcitabine after chemotherapy may help mesothelioma patients live longer than supportive care alone. …
-
-
Cholesterol Drugs Extend Mesothelioma Survival in New Study
Cholesterol drugs called statins have been shown to improve survival among mesothelioma patients taking PD-1 inhibitors. The news comes from… -
Chemotherapy | Europe | International | Multi-Modality Therapy | New Studies | Research | Treatments
Induction Chemotherapy with Avastin Improves Mesothelioma Response in New Study
Mesothelioma patients who had induction chemotherapy with Avastin (bevacizumab) prior to surgery responded better than those who had only chemotherapy… -
Age is a Factor in Mesothelioma Survival After Surgery
Age appears to be one of the biggest predictors of mesothelioma survival after surgery. This holds true no matter which… -
Long-Term Mesothelioma Survival: Follow-up is Critical
A newly published French case report is a reminder that long-term mesothelioma survival requires long-term follow-up. The case comes from… -
Multimodal Mesothelioma Treatment Doubles Survival in Mexican Study
Researchers at Mexico’s National Cancer Institute say multimodal mesothelioma treatment with chemotherapy, surgery, and radiation can slow tumor growth and… -
Keytruda and Tumor Treating Fields: New Hope for Mesothelioma?
There is hope that a new lung cancer trial combining Keytruda and Tumor Treating Fields could lead to a new… -
First-Line Immunotherapy May Be Better Than Chemo for This Mesothelioma Subtype
A new study suggests that people with sarcomatoid mesothelioma may fare better if they have first-line immunotherapy before considering chemotherapy. … -
Long Term Peritoneal Mesothelioma Survival with NIPEC
A new report suggests that long term peritoneal mesothelioma survival may be possible with a treatment called NIPEC and the… -
Immunotherapy with Durvalumab: Record Survival in Inoperable Mesothelioma
There is new evidence that the immunotherapy drug durvalumab may make chemotherapy more effective for people with inoperable pleural mesothelioma.…
